Retatrutide and the Future of Obesity Treatment: Insights from the TRIUMPH-1 Study The landscape of obesity medicine is evolving rapidly. Eli Lilly’s investigational drug, retatrutide, has recently garnered significant attention …
Tag:
Semaglutide
-
-
Health
How GLP-1s are more than just weight-loss wonders – but not without risk – South China Morning Post
Understanding GLP-1 Agonists: A Comprehensive Guide to Modern Metabolic Treatment In recent years, the medical landscape has been transformed by a class of medications known as glucagon-like peptide-1 (GLP-1) receptor …
-
Zydus Lifesciences Reports Growth in Q4 FY26 Financial Results Zydus Lifesciences has reported its financial performance for the fourth quarter (Q4) of the 2025-26 financial year (FY26), highlighting a period …
-
Exploring the Benefits and Risks of GLP-1 Receptor Agonists GLP-1 receptor agonists, such as semaglutide, tirzepatide, and liraglutide, have garnered significant attention for their role in managing weight and metabolic …
-
Wegovy vs. Ozempic: Which GLP-1 Medication Is Right for You? Wegovy and Ozempic are two medications that have gained significant attention for their effectiveness in weight management and diabetes treatment. …
-
Weight Loss Drug Semaglutide Fails to Leisurely Alzheimer’s Progression Despite initial optimism stemming from observational studies and biomarker changes, recent Phase 3 clinical trials published in The Lancet have demonstrated …
-
China Approves First Commercially Available Brain-Computer Interface China has taken a significant step forward in neurotechnology, granting commercial approval for the country’s first brain-computer interface (BCI) device. Developed by Shanghai-based …
-
Ozempic and Mental Health: New Study Links Diabetes Drug to Improved Mood and Reduced Substance Leverage A groundbreaking new study published in The Lancet Psychiatry reveals a significant link between …
-
GLP-1 Weight Loss Drugs: Many Patients Restart or Switch Therapies After Stopping A recent study indicates that many individuals who discontinue glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications for weight …
-
Gut Microbiome May Predict Response to GLP-1 Weight Loss Medications New research highlights the growing understanding of how the gut microbiome influences the effectiveness of glucagon-like peptide-1 receptor agonists (GLP-1 …
Newer Posts